查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1521116

2024-2032 年临床试验管理系统市场报告（按组件、部署模式、最终用户和区域）

Clinical Trial Management Systems Market Report by Component, Deployment Mode, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球临床试验管理系统市场规模达11.468亿美元。 The clinical trial management systems (CTMS) market is propelled by factors such as increasing clinical trial complexity, rising adoption of cloud-based CTMS solutions for remote collaboration, stringent regulatory requirements, and the growing emphasis on patient-centric trials for improved efficiency and 资料品质.

临床试验管理系统市场分析：

主要市场驱动因素：多站点临床试验日益复杂以及云端技术的逐渐采用推动了临床试验管理系统市场的成长。考虑到对试验管理模组的需求增加，市场规模可能会大幅成长。

主要市场趋势：临床试验管理系统展望展示了分散临床试验、虚拟试验平台和基于风险的监控方法的使用率上升等趋势。此外，人们越来越重视与现有试验系统和软体平台的互连性和整合。

地区趋势：北美在 CTMS 市场上处于领先地位，因为它开发了先进的医疗基础设施并正在进行大量的研发活动。然而，由于医疗旅游和基础设施改善而市场快速成长的亚太和拉丁美洲地区也在提供临床试验外包服务。

竞争格局：临床试验管理系统产业的一些主要市场参与者包括 Advarra Inc.、ArisGlobal LLC、BioClinica Inc.、DataTrak International Inc.、DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)、International Business Machines Corporation、 Medidata Solutions Inc. (Dassault Systemes SE)、MedNet Solutions Inc.、Oracle Corporation、Parexel International Corporation、RealTime Software Solutions LLC、Veeva Systems Inc. 等。

挑战与机会：市场面临资料保护问题、互通性问题与监管挑战等挑战。它还提供了机会，这些机会可以透过实施高级分析、现实世界证据整合和去中心化试验模型来确定。

临床试验管理系统市场趋势：

增加临床试验的复杂性

精准和个人化医疗的发展加剧了临床试验的复杂性，需要复杂的管理解决方案。 CTMS 平台透过为研究计划、方案设计、患者入组和资料管理提供全面的解决方案，在管理这些复杂的试验中发挥关键作用。透过简化流程并促进利害关係人之间的协作，CTMS 平台可协助组织有效应对现代临床研究的复杂性，确保遵守严格的协议并加速创新疗法的开发。这些平台利用人工智慧和机器学习等先进技术来优化试验设计和执行，提高效率并产生临床试验管理系统收入。

严格的监管要求

监管机构制定了严格的指导方针来维护病患安全和资料完整性，因此需要 CTMS 平台提供强大的合规管理。 CTMS 解决方案提供强大的工具和功能来帮助组织履行这些监管义务。从确保协议遵守和文件管理到促进审计准备和监管报告，CTMS 平台可协助组织自信地应对复杂的监管环境，降低合规风险并确保遵守监管标准。此外，CTMS平台还整合了自动合规监控和即时风险评估等功能，可主动识别和解决监管问题，提高整体合规效率和有效性。例如，美国的临床试验法规受到严格的指导方针的约束，例如《2022 年食品和药品综合改革法案》(FDORA)、《1974 年隐私法案》以及《NIH 隐私和保密政策手册》。

强调以病人为中心的试验

随着向以患者为中心的转变，CTMS 平台优先考虑患者招募入口网站和远端监控等功能，以提高患者参与度和试验成功率。人们越来越认识到临床研究中以患者为中心的重要性，重点是提高患者的参与度、体验和保留率。 CTMS 平台透过整合病患招募入口网站、远端监控功能和电子病患报告结果 (ePRO) 等功能来支援这种范式转移。透过为患者提供积极参与和沟通的工具，CTMS 平台可以提高患者的依从性，提高资料质量，并最终有助于以患者为中心的试验的成功。这正在创造积极的临床试验管理系统市场概况。

临床试验管理系统市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据组件、部署模式和最终用户对市场进行了分类。

按组件划分：

软体

服务

软体占大部分市场份额

该报告根据组成部分提供了详细的市场细分和分析。这包括软体和服务。根据该报告，软体占据了最大的部分。

软体在 CTMS 市场中不断扩大的渗透率主要是由于增加灵活性、可扩展性和客製化的潜力所致。由于临床试验生态系统有不同的利害关係人，软体产品为试验设计、受试者招募、资料管理和监管合规性提供客製化功能。除此之外，SaaS 模型有助于实现经济高效的部署和易于访问，特别是对于中小型组织而言。临床试验的日益复杂性以及对高级分析和即时洞察的隐含需求使得软体成为试验工作流程管理、流程改进和药物开发加速的核心。例如，美国联邦政府透过卫生与公众服务部 (HHS) 和美国国立卫生研究院 (NIH) 提出了政策变更，透过扩大试验註册要求和资料共享来提高研究透明度，以提高临床试验透明度。

按部署模式划分：

网路为基础的 CTMS

本地部署

基于云端的CTMS

基于Web的CTMS占据业界最大份额

报告还根据部署模式对市场进行了详细的细分和分析。这包括基于 Web 的 CTMS、本地 CTMS 和基于云端的 CTMS。报告显示，基于网路的CTMS占据了最大的市场份额。

基于网路的 CTMS 作为部署模式主导 CTMS 市场，因为基于网路的方法提供了更多的可用性和便利性，因为使用者可以从全球任何有网路连线的位置存取该系统。这使得利害关係人团队可以远端工作并随时存取资料，确保试验的顺利进行。此外，与现场安装相比，线上 CTMS 系统通常具有较低的初始成本和较少的 IT 基础设施投资，这使得它们成为寻求经济且可扩展的试验管理解决方案的中小型组织的绝佳选择。例如，Sitero 最近收购了Clario eClinical 套件，其中包括Mentor CTMS，这是一种基于Web 的CTMS 解决方案，它具有多种优势，例如简单且经济实惠的第三方eTMF 整合、不受限制的存取、熟悉的基于Microsoft Office 的介面、快速实作以及行动功能，满足高效率且使用者友善的 CTMS 平台的需求。

按最终用户划分：

製药和生物技术公司

合约研究组织

其他的

製药和生物技术公司代表了领先的细分市场

该报告提供了基于最终用户的详细市场细分和分析。这包括製药和生物技术公司、合约研究组织等。根据该报告，製药和生物技术公司占据了最大的市场份额。

临床试验变得越来越复杂且受到严格审查，使得製药和生物技术公司有必要作为最终用户每天采用 CTMS 解决方案。 CTMS 平台具有全方位的功能，专为製药和生物技术公司的使用而定制，因此可以无缝地进行试验操作。不同利害关係人的合作得到加强，此外，监管合规性得到维持，疗法的开发速度也更快。此外，CTMS 系统有助于这些实体减少资源利用率、控制临床试验成本并提高整体组织生产力，从而改善临床试验管理系统市场统计数据。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的临床试验管理系统市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美在临床试验管理系统市场占有领先地位。

北美凭藉其强大的医疗基础设施、广泛的临床研究活动和严格的监管标准推动了 CTMS 市场的发展。该地区拥有众多进行临床试验的製药、生物技术和医疗器材公司，对 CTMS 解决方案产生了巨大的需求。此外，慢性病的流行和对创新疗法的需求进一步推动了先进试验管理工具的采用。此外，北美在研发方面的大量投资，加上其技术进步和对精准医疗的关注，促进了 CTMS 市场的成长。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。临床试验管理系统产业的一些主要市场参与者包括 Advarra Inc.、ArisGlobal LLC、BioClinica Inc.、DataTrak International Inc.、DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)、International Business Machines Corporation、Medidata Solutions Inc . (Dassault Systemes SE)、MedNet Solutions Inc.、Oracle Corporation、Parexel International Corporation、RealTime Software Solutions LLC 与Veeva Systems Inc.

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

CTMS 市场的主要参与者专注于创新和策略合作伙伴关係，以增强其产品并扩大市场占有率。他们正在投资人工智慧和机器学习等先进技术，以提高试验效率和资料分析能力，从而提供全球临床试验管理系统市场机会。此外，这些公司还与製药公司、合约研究组织和学术机构合作，开发综合解决方案，以满足临床研究不断变化的需求。此外，他们还透过收购和区域扩张来扩大其全球足迹，以进入新兴市场并利用全球对 CTMS 解决方案不断增长的需求。例如，2023 年 9 月 27 日，以其临床研究服务和技术解决方案而闻名的 Emmes 现在正在利用其优势 eClinical 平台的远距医疗功能。 Emmes 将这些生产力和操作工具结合到一个策略计划中，这证实了其致力于提供更全面的服务并满足临床研究不断变化的领域的要求的承诺。

临床试验管理系统市场最新发展：

2022 年 10 月 17 日：为生命科学领域提供基于云端的软体解决方案的高科技公司 Veeva Systems Inc. 与 40 多家合约研究组织 (CRO) 签署了策略协议。此次合作旨在部署完整的试验解决方案技术，其中包括屡获殊荣的 Veeva Vault CTMS（临床试验管理系统）。透过利用具有共同目标的广泛 CRO 的经验和营运能力，Veeva 旨在提高其最先进的 CTMS 平台的使用率。

2022 年 6 月 27 日：全球知名的云端生命科学供应商 Medidata Solutions Inc.（达梭系统 SE）最近推出了临床操作技术。这些新颖的产品是为了满足这些参与者在临床试验管理和监控方面的主要需求而发明的。 Medidata 利用人工智慧和预测分析等先进技术，致力于提高试验效能、提高资料品质并增强病患安全。这些新技术的推出突显了 Medidate 对临床研究创新的奉献精神，并为公司配备了工具，以放心地解决当前药物开发的复杂问题。

本报告回答的关键问题

  • 2023年全球临床试验管理系统市场规模有多大
  • 2024-2032年全球临床试验管理系统市场的预期成长率是多少
  • COVID-19 对全球临床试验管理系统市场有何影响
  • 推动全球临床试验管理系统市场的关键因素是什么
  • 基于组件的全球临床试验管理系统市场的细分是什么
  • 基于部署模式的全球临床试验管理系统市场区隔是怎样的
  • 基于最终用户的全球临床试验管理系统市场的细分是什么
  • 全球临床试验管理系统市场的重点区域有哪些
  • 谁是全球临床试验管理系统市场的主要参与者/公司

本报告回答的关键问题

  • 2023年全球临床试验管理系统市场规模有多大？ 2024-2032年全球临床试验管理系统市场的预期成长率是多少？
  • COVID-19 对全球临床试验管理系统市场有何影响？
  • 推动全球临床试验管理系统市场的关键因素是什么？
  • 基于组件的全球临床试验管理系统市场的细分是什么？
  • 全球临床试验管理系统市场依部署模式划分是怎样的？
  • 基于最终用户的全球临床试验管理系统市场的细分是什么？
  • 全球临床试验管理系统市场的关键区域有哪些？
  • 谁是全球临床试验管理系统市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球临床试验管理系统市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按组成部分

  • 软体
    • 市场走向
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依部署模式

  • 网路为基础的 CTMS
    • 市场走向
    • 市场预测
  • 本地部署
    • 市场走向
    • 市场预测
  • 基于云端的CTMS
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 合约研究组织
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Advarra Inc.
    • ArisGlobal LLC
    • BioClinica Inc.
    • DataTrak International Inc.
    • DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)
    • International Business Machines Corporation
    • Medidata Solutions Inc. (Dassault Systemes SE)
    • MedNet Solutions Inc.
    • Oracle Corporation
    • Parexel International Corporation
    • RealTime Software Solutions LLC
    • Veeva Systems Inc.
Product Code: SR112024A4984

The global clinical trial management systems market size reached US$ 1,146.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,682.0 Million by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The clinical trial management systems (CTMS) market is propelled by factors such as increasing clinical trial complexity, rising adoption of cloud-based CTMS solutions for remote collaboration, stringent regulatory requirements, and the growing emphasis on patient-centric trials for improved efficiency and data quality.

Clinical Trial Management Systems Market Analysis:

Major Market Drivers: The clinical trial management systems market growth is fueled by the growing complexity of multisite clinical trials and the gradual adoption of cloud technology. The market size will potentially grow to a considerable extent considering enhanced requirement for trial management modules.

Key Market Trends: The clinical trial management system outlook showcases trends such as the rise in utilization of decentralized clinical trials, the virtual trial platforms, and risk-based monitoring methods. Moreover, there is an increasing emphasis on interconnectivity and integration with existing trial systems and software platforms.

Geographical Trends: North America owns the leading position in CTMS market as it has developed advanced healthcare infrastructure and is conducting numerous research and development activities. However, the Asia-Pacific and Latin America regions, which are undergoing rapid market growth because of medical tourism and improving infrastructure, are also offering clinical trial outsourcing services.

Competitive Landscape: Some of the major market players in the clinical trial management systems industry include Advarra Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines Corporation, Medidata Solutions Inc. (Dassault Systemes SE), MedNet Solutions Inc., Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC, Veeva Systems Inc., among many others.

Challenges and Opportunities: The market faces challenges such as data protection issues, interoperability issues and regulatory challenges. It also offers opportunities, such opportunities can be determined from implementation of the advanced analytics, real-world evidence integration, and decentralized trial models.

Clinical Trial Management Systems Market Trends:

Increasing Clinical Trial Complexity

The evolution of precision and personalized medicine has intensified the intricacies of clinical trials, demanding sophisticated management solutions. CTMS platforms play a pivotal role in managing these intricate trials by providing comprehensive solutions for study planning, protocol design, patient enrollment, and data management. By streamlining processes and facilitating collaboration among stakeholders, CTMS platforms help organizations effectively navigate the complexities of modern clinical research, ensuring adherence to rigorous protocols and accelerating the development of innovative therapies. These platforms leverage advanced technologies such as artificial intelligence and machine learning to optimize trial design and execution, enhancing efficiency and generating clinical trial management systems revenue.

Stringent Regulatory Requirements

Regulatory bodies impose rigorous guidelines to uphold patient safety and data integrity, necessitating robust compliance management offered by CTMS platforms. CTMS solutions offer robust tools and functionalities to assist organizations in meeting these regulatory obligations. From ensuring protocol adherence and documentation management to facilitating audit readiness and regulatory reporting, CTMS platforms help organizations navigate the complex regulatory landscape with confidence, reducing compliance risks and ensuring adherence to regulatory standards. Additionally, CTMS platforms incorporate features such as automated compliance monitoring and real-time risk assessment to proactively identify and address regulatory issues, enhancing overall compliance efficiency and effectiveness. For instance, the regulations for clinical trials in the United States are governed by stringent guidelines such as the Food and Drug Omnibus Reform Act of 2022 (FDORA), Privacy Act of 1974, and the NIH Policy Manual on Privacy and Confidentiality.

Emphasis on Patient-Centric Trials

With a shift toward patient-centricity, CTMS platforms prioritize features like patient recruitment portals and remote monitoring to enhance patient engagement and trial success. There is a growing recognition of the importance of patient-centricity in clinical research, with a focus on enhancing patient engagement, experience, and retention. CTMS platforms support this paradigm shift by incorporating features such as patient recruitment portals, remote monitoring capabilities, and electronic patient-reported outcomes (ePRO). By empowering patients with tools for active participation and communication, CTMS platforms improve patient compliance, enhance data quality, and ultimately contribute to the success of patient-centric trials. This is creating a positive clinical trial management systems market overview.

Clinical Trial Management Systems Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on component, deployment mode, and end user.

Breakup by Component:

Software

Services

Software accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the component. This includes software, and services. According to the report, software represented the largest segment.

The expanding penetration of software in the CTMS market is mainly induced by the potential for added flexibility, scalability, and customization. Software offerings provide bespoke functions for trial design, subject recruitment, data management, and regulatory conformity as clinical trial ecosystem has different stakeholders. Apart from this, SaaS models facilitate in having cost-effective deployment and easy accessibility, especially for the small and mid-sized organizations. The growing sophistication of the clinical trials and implicit need for advanced analytics and real-time insights has placed software at the heart of trial workflow management, process improvement, and drug development speedup. For instance, the U.S. Federal Government, through the Department of Health and Human Services (HHS) and the National Institutes of Health (NIH), has proposed policy changes to improve clinical trial transparency by expanding trial registration requirements and data sharing to enhance research transparency.

Breakup by Deployment Mode:

Web-based CTMS

On-premise

Cloud-based CTMS

Web-based CTMS holds the largest share of the industry

A detailed breakup and analysis of the market based on the deployment mode have also been provided in the report. This includes web-based CTMS, on-premise, and cloud-based CTMS. According to the report, web-based CTMS accounted for the largest market share.

The web-based CTMS as a deployment mode dominates the CTMS market as web-based methods provide more availability and convenience as users can access the system from any location worldwide where there is internet connection. This makes it possible for a stakeholder team to work remotely and have ready data access, ensuring the smooth running of trials. Moreover, online CTMS systems typically have lower initial costs and fewer IT infrastructure investments than on-site installations making them to be terrific options to small and mid-sized organization looking for an economical and scalable trials management solutions. For instance, Sitero recently acquired the Clario eClinical suite including, Mentor CTMS, a web-based CTMS solution offer benefits, such as easy and affordable third-party eTMF integration, unrestricted access, a familiar Microsoft Office-based interface, rapid implementation, and mobility-enabled features, catering to the demand for efficient and user-friendly CTMS platforms.

Breakup by End User:

Pharmaceutical and Biotechnology Firms

Contract Research Organizations

Others

Pharmaceutical and biotechnology firms represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes pharmaceutical and biotechnology firms, contract research organizations, and others. according to the report, pharmaceutical and biotechnology firms represented the largest market share.

Clinical trials are becoming more complex and highly scrutinized making it necessary for pharmaceuticals and biotechnology companies to incorporate CTMS solutions on a daily basis as the end users. CTMS platforms furnish with all-encompassing features that are meant to be customized for the use of the pharmaceutical and biotech companies, and hence trials operations can be seamlessly carried out. The collaboration of different stakeholders is enhanced and, besides, regulatory compliance is maintained, and therapies developed much faster. Furthermore, CTMS systems are useful to these entities in reducing resources utilization, controlling the clinical trial costs and improving the overall organization productivity, thus improving the clinical trial management systems market statistics.

Breakup by Regional:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest clinical trial management systems market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America holds the leading position in the market for clinical trial management systems.

North America drives the CTMS market due to its robust healthcare infrastructure, extensive clinical research activities, and stringent regulatory standards. The region hosts numerous pharmaceutical, biotechnology, and medical device companies conducting clinical trials, creating a significant demand for CTMS solutions. Additionally, the prevalence of chronic diseases and the need for innovative therapies further fuel the adoption of advanced trial management tools. Moreover, North America's substantial investments in research and development, coupled with its technological advancements and focus on precision medicine, contributing to the the CTMS market growth.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the clinical trial management systems industry include Advarra Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines Corporation, Medidata Solutions Inc. (Dassault Systemes SE), MedNet Solutions Inc., Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC and Veeva Systems Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the CTMS market are focusing on innovation and strategic partnerships to enhance their offerings and expand their market presence. They are investing in advanced technologies such as artificial intelligence and machine learning to improve trial efficiency and data analytics capabilities, thereby providing the global clinical trial management systems market opportunities. Additionally, these companies are collaborating with pharmaceutical firms, contract research organizations, and academic institutions to develop integrated solutions that address the evolving needs of clinical research. Moreover, they are expanding their global footprint through acquisitions and regional expansions to tap into emerging markets and capitalize on the growing demand for CTMS solutions worldwide. For instance, On 27 September 2023, Emmes, known for its clinical research services and technology solutions, is now utilizing telehealth features of its advantage eClinical platform. Emmes' move of combining these productivity and operating tools under a single strategic plan confirms its commitment to delivering more integrated services and meeting the requirements of the continuously shifting terrain in clinical research.

Clinical Trial Management Systems Market Recent Developments:

October 17, 2022: Veeva Systems Inc., the high-tech company supplying cloud- based software solutions for the life sciences sector, signed a strategic agreement with over 40 Contract Research Organizations (CROs). The collaboration sought to deploy a complete trial solutions technology, which is the award-winning Veeva Vault CTMS (Clinical Trial Management System) among others. Through leveraging the experience and operational capabilities of a broad spectrum of CROs with a common goal, Veeva aimed at the increased usage of its state-of-the-art CTMS platform.

June 27, 2022: Medidata Solutions Inc. (Dassault Systemes SE), world-renowned vendor of life sciences based in the cloud, has recently introduced clinical operation technologies. These novel products are invented to cope with major needs of these players in clinical trials management and monitoring. Harnessing advanced technologies, such as artificial intelligence and predictive analytics, Medidata strives for better trial performance, improved data quality, and enhanced patient safety. The introduction of these novel technologies underlines Medidate's dedication to innovation in clinical research as well as equipping companies with tools to address the intricacies of drug development of the current time with assuredness.

Key Questions Answered in This Report

  • 1. What was the size of the global clinical trial management systems market in 2023?
  • 2. What is the expected growth rate of the global clinical trial management systems market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global clinical trial management systems market?
  • 4. What are the key factors driving the global clinical trial management systems market?
  • 5. What is the breakup of the global clinical trial management systems market based on the component?
  • 6. What is the breakup of the global clinical trial management systems market based on the deployment mode?
  • 7. What is the breakup of the global clinical trial management systems market based on the end user?
  • 8. What are the key regions in the global clinical trial management systems market?
  • 9. Who are the key players/companies in the global clinical trial management systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Trial Management Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Mode

  • 7.1 Web-based CTMS
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 On-premise
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cloud-based CTMS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Firms
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Advarra Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 ArisGlobal LLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BioClinica Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 DataTrak International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 DZS Clinical Services Inc. (WDB Holdings Co. Ltd.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 International Business Machines Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medidata Solutions Inc. (Dassault Systemes SE)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 MedNet Solutions Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Oracle Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Parexel International Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 RealTime Software Solutions LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Veeva Systems Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Clinical Trial Management Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Clinical Trial Management Systems Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Clinical Trial Management Systems Market: Breakup by Deployment Mode (in %), 2023
  • Figure 6: Global: Clinical Trial Management Systems Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Clinical Trial Management Systems Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Clinical Trial Management Systems (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Clinical Trial Management Systems (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Clinical Trial Management Systems (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Clinical Trial Management Systems (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Clinical Trial Management Systems (Web-based CTMS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Clinical Trial Management Systems (Web-based CTMS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Clinical Trial Management Systems (On-premise) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Clinical Trial Management Systems (On-premise) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Clinical Trial Management Systems (Cloud-based CTMS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Clinical Trial Management Systems (Cloud-based CTMS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Clinical Trial Management Systems (Pharmaceutical and Biotechnology Firms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Clinical Trial Management Systems (Pharmaceutical and Biotechnology Firms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Clinical Trial Management Systems (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Clinical Trial Management Systems (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Clinical Trial Management Systems (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Clinical Trial Management Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Clinical Trial Management Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Clinical Trial Management Systems Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Clinical Trial Management Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Clinical Trial Management Systems Industry: SWOT Analysis
  • Figure 74: Global: Clinical Trial Management Systems Industry: Value Chain Analysis
  • Figure 75: Global: Clinical Trial Management Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Trial Management Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Clinical Trial Management Systems Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Clinical Trial Management Systems Market Forecast: Breakup by Deployment Mode (in Million US$), 2024-2032
  • Table 4: Global: Clinical Trial Management Systems Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Clinical Trial Management Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Clinical Trial Management Systems Market: Competitive Structure
  • Table 7: Global: Clinical Trial Management Systems Market: Key Players